BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35150198)

  • 1. Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway.
    Wang J; Quan Y; Lv J; Gong S; Ren P
    Environ Toxicol; 2022 Jun; 37(6):1343-1356. PubMed ID: 35150198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
    Li C; Yang J; Lei S; Wang W
    Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling.
    Li C; Yang J; Wang W; Li R
    J Bioenerg Biomembr; 2021 Feb; 53(1):61-71. PubMed ID: 33394310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling.
    Zhang J; Liu Y; Pu S; He J; Zhou C
    Breast Cancer Res Treat; 2021 Feb; 186(1):247-258. PubMed ID: 33423159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 regulates FAM83D m
    Yu X; Li Y; Kong F; Xu Q
    Toxicol In Vitro; 2024 Mar; 95():105746. PubMed ID: 38043628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
    Tomar VS; Patil V; Somasundaram K
    Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
    Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
    Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway.
    Hua YQ; Zhang K; Sheng J; Ning ZY; Li Y; Shi WD; Liu LM
    Life Sci; 2021 Dec; 287():119205. PubMed ID: 33571515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
    Zhu H; Diao S; Lim V; Hu L; Hu J
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt.
    Ma S; Quan P; Yu C; Fan X; Yang S; Jia W; Zhang L; Wang F; Liu F; Yang L; Qin W; Yang X
    Biochem Biophys Res Commun; 2021 Sep; 571():66-73. PubMed ID: 34303965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F; Pan Q; Yu H; Yue X
    J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
    Feng X; Jiang J; Sun L; Zhou Q
    Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
    Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
    J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
    Wang M; Li C; Shi W
    Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.
    Li W; Miao X; Liu L; Zhang Y; Jin X; Luo X; Gao H; Deng X
    Oncotarget; 2017 Apr; 8(15):25167-25176. PubMed ID: 28445937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
    Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.